ALK’s partner, Torii, submits registration application for the house dust mite SLIT-tablet
ALK announced that its partner, Torii, has submitted a New Drug Application in Japan for ALK’s house dust mite sublingual allergy immunotherapy tablet for the indication of allergic rhinitis. The HDM SLIT-tablet is also currently under review by the European authorities. January 26, 2015